Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

NVIDIA stock or Pro Medicus (ASX:PME) shares? Plus results from MFST, META, AAPL & more

On the Australian Investors Podcast, Owen Rask and Drew Meredith, CFP take a look the market darlings Pro Medicus Ltd and NVIDIA Inc.

Listen to the podcast now

Play Video

Topics covered:

– NVDA stock or PME shares?

– Results from MSFT, AAPL SPOT & META – Rex is closing down

– iShares S&P 500 (ASX: IVV) or VanEck QUAL ETF (ASX: QUAL)?

– The best free investment resources

– How to calculate PE ratios

If you ❤️ this episode, you’ll LOVE our series. Episodes go live every Saturday at 7 am and Wednesday arvo.

We air an interview with an Australian or international investing expert every Wednesday, and Q&A every Saturday! Subscribe below.

Episode resources

Podcast resources

Say g'day to these great resources 👇

The information on this website and in our podcasts is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.

Share this episode:

Like Rask podcasts? Get Owen's weekly newsletter.

Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 50,000 Australians on Rask’s mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.

Skip to content